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Abstract
Background: Childhood obesity and asthma are increasing worldwide. A possible
link between the two conditions has been postulated.
Methods: Cross-sectional studies of stratified random samples of 8–12-year-old
children (n510 652) (16 centres in affluent and 8 centres in non-affluent countries)
used the standardized methodology of ISAAC Phase Two. Respiratory and allergic
symptoms were ascertained by parental questionnaires. Tests for allergic disease
were performed. Height and weight were measured, and overweight and obesity
were defined according to international definitions. Prevalence rates and
prevalence odds ratios were calculated.
Results: Overweight (odds ratio51.14, 95%-confidence interval: 0.98; 1.33) and
obesity (odds ratio51.67, 95%-confidence interval: 1.25; 2.21) were related to
wheeze. The relationship was stronger in affluent than in non-affluent centres.
Similar results were found for cough and phlegm, rhinitis and eczema but the
associations were mostly driven by children with wheeze. There was a clear
association of overweight and obesity with airways obstruction (change in FEV1/
FVC, 20.90, 95%-confidence interval: 21.33%; 20.47%, for overweight and
22.46%, 95%-confidence interval: 23.84%; 21.07%, for obesity) whereas the
results for the other objective markers, including atopy, were null.
Conclusions: Our data from a large international child population confirm that
there is a strong relation of body mass index with wheeze especially in affluent
countries. Moreover, body mass index is associated with an objective marker of
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airways obstruction (FEV1/FVC) but no other objective markers of respiratory and
allergic disorders.
Introduction
The prevalence of obesity in childhood is increasing in many countries worldwide.
Secular trends of increased obesity and asthma prevalence in adults and children
during the past decades have led to a debate about potential links between both
conditions. Suggested mechanisms to explain this association includes mechan-
ical, lifestyle, dietary, immunological, hormonal, and common genetic factors [1].
There is evidence from cross-sectional studies [2, 3] that obesity is associated
with asthma in childhood [4–6]. Prospective cohort studies show associations
between obesity and incidence [7, 8] and persistence of asthma [9]. In a cohort
study, overweight children had higher risk of asthma symptoms and bronchial
hyper-responsiveness (BHR) at 8 years [10]. Although there is evidence of a link
between obesity and asthma in children from predominantly western populations,
little is known about less affluent regions and the under-lying mechanisms [11]. A
recent report from the International Study of Asthma and Allergies in Childhood
(ISAAC) Phase Three, a cross-sectional study, revealed associations between
overweight and obesity and symptoms of asthma and eczema but not
rhinoconjunctivitis [12]. However, no systematic evaluation of the association of
objectively measured weight and height, with questionnaire reports together with
objective measures of allergy and lung function has been available.
Despite the growing research over the obesity/asthma relationship, little is
known about worldwide variation in the relationship of excess body mass index
(BMI) and the prevalence of respiratory symptoms and allergic disease, and even
less regarding objective markers for allergy and respiratory function. The ISAAC
Phase Two study is ideally suited to address these issues because it includes a large
number of children in geographically and economically diverse regions with data
on various objective markers, and measured BMI in addition to a range of
reported symptoms.
Methods
Study populations and field work
The methods of ISAAC Phase Two have been described in detail elsewhere [13].
Briefly, random samples of at least 10 schools from defined geographical areas
were chosen and children (n.1 000 per centre) attending classes with a majority
of 9–11-year-olds were invited to participate. Standardized parental question-
naires were used. In three countries (Ghana, Brazil and India) the questions were
posed by trained interviewers because illiteracy was common.
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The ISAAC Phase Two methodology allowed objective measurements to be
performed either in the full sample (option A) or in random subsamples of
children, generally stratified by wheeze (option B) [13]. Most centres invited all
children to participate in the skin prick testing, while blood sampling, BHR tests
and anthropometric measurements were carried out mostly in stratified random
subsamples of children with and without reports of wheeze in the past year
(targeting 100 per centre in each stratum).
Fuller details of the skin examination, lung function measurements and BHR,
total immunglobulin E (IgE) measurements and skin prick tests to six
aeroallergens (Dermatophagoides pteronyssinus, D. farinae, cat dander, Alternaria
tenuis, mixed tree pollen and mixed grass pollen) have been published elsewhere
[13] and can be found at http://isaac.auckland.ac.nz/phases/phasetwo/phasetwo.
html.
Symptoms data
Standardized parental questionnaires, including detailed questions on the
occurrence and severity of symptoms of asthma (wheeze), rhinitis (with and
without conjunctivitis) and flexural eczema were administered. In this context,
wheezing is regarded as indicator symptom for asthma. These were identical to
those used in ISAAC Phase One for parents of children aged 6–7 years [13]. In
addition, in many (but not all) centres, questions about cough and phlegm were
asked (http://isaac.auckland.ac.nz/phases/phasetwo/phasetwo.html and Online-
Repository in File S1).
Assessment of adiposity
Weight and height were measured without shoes and BMI was calculated. We
used the age and sex specific BMI cut points for overweight and obesity derived
from an international data set by Cole et al [14]. These cut points are based on age
and sex specific percentile curves that were shown to correspond to the adult cut
points of 25 and 30 kg/m2 for overweight and obesity, respectively. This
procedure has the advantage of being independent of the prevalence of obesity in
the individual study centres, thereby enabling their comparison and combining of
results.
Statistical analysis
Prevalence, population means and linear and logistic regression for health
outcomes were calculated with the SURVEY-procedures of SAS (V9.2) using the
appropriate weighting and variance estimation to account for stratified
subsampling [15] where necessary. Total IgE as an outcome was dichotomized at
the median (4.17 kU/l). Separate regression models were fitted for each centre and
combined estimates of the effect estimates were derived using random effects
meta-analysis [16]. Associations are presented as odds ratios (OR) or change in
the parameter of interest. Forced expiratory volume in one second (FEV1) and
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forced vital capacity (FVC) as measured during spirometry were used in the
statistical analysis, adjusting for age, gender and height, rather than using
predicted values which may not be applicable in a large global setting with
different child populations [17].
Potential confounders were tested by including them one by one in the centre-
specific models and only those that resulted in a notable (10% or greater) change
of the combined estimate were retained. The potential confounders included sex,
age, diet (fruit and vegetable intake), Mediterranean diet, physical activity,
reported parental allergic disease, maternal education, birth weight, breastfeeding,
maternal smoking in pregnancy, anybody smoking in the child’s home, and damp
spots or moulds in the child’s home. Based on the change-in-parameter criterion,
only sex was retained in the fully adjusted model. Adjustment with physical
activity and diet did not result in any change of the estimates but reduced the
study population by about half. Results using adjustment for all other tested
factors are presented in table S2 in File S2. Models for lung function (FEV1, FVC)
were adjusted for age, sex and height.
The influence of potential effect modifiers was investigated by performing
stratified centre-specific analyses, calculating the combined effect for each stratum
and evaluating the difference between strata-specific estimates. Due to small cell
counts in some centres in specific strata, the number of centres contributing to the
stratum-specific estimates may differ from the number of centres in the
corresponding unstratified analyses.
Centres classified by the World Bank as ‘high income countries’ (i.e. gross
national income (GNI) per capita per year in 2001§ 9 200 US $) were combined
in a group called ‘affluent countries’ and the remaining centres in a group called
‘non-affluent countries’ [18].
Ethics statement
All centres obtained approval by local ethics committees and investigators were
trained in one location to assure comparable data quality. Almeria, Cartagena,
Madrid, Valencia (all Spain): Ethics Committee of the ‘‘12 de Octubre’’ Hospital
in Madrid; Tirana (Albania): National Ethics Committee; Tallinn (Estonia): The
Medical Research Ethics Committee of Estonian Institute of Experimental and
Clinical Medicine; Creteil (France): Comite Consultatif de Protection des
Personnes dans la recherche´ biomedicale- Marseille 2; Dresden, Munich (both
Germany): Ethics Committee of the University of Mu¨nster; Athens, Thessaloniki
(both Greece): Hippokration General Hospital Ethical Committee; Rome (Italy):
Ethic Committee of catholic University, Rome; Reykjavik (Iceland): National
Bioethics Committee; Utrecht (Netherlands): Medical Ethical Committee of
Wageningen University; Tromso (Norway): Regional Medical Ethics Committeee
Norwegian Data Inspectorate; Linkoeping, Oestersund (both Sweden): Ethics
committee at Linko¨ping and Umea University; Ankara (Turkey): Ethics
committee of Hacettepe University Faculty of Medicine; Ethics committee of the
Turkish Ministry of Health; West Sussex (UK): Local Research Ethics Committee
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for Mid-Downs Health Authority; Hawkes Bay (New Zeland): Hawkes Bay Ethics
Committee; Hong Kong (China): Ethics Committee of the Chinese University of
Hong Kong; Beijing (China): Ethics Committee of Capital Institute of Paediatrics,
Beijing; Guangzhou (China): Ethics Committee of Guangzhou Institute of
Respirating Diseases; Kintampo (Ghana): London school of Hygiene and Tropical
Medicine Ethics Committee; Mumbai (India): Jaslok Hospital; Uruguaiana
(Brazil): Comite de Etica e Pesquisa da Pontificia Universidade Catolica do RGS;
Pichincha (Ecuador): Saludesa/Hospital Pedro Vicente Maldonado Ad Hoc Ethics
Committee; Tbilisi (Georgia): Bioethics National Counsil of Ministry of Labor,
Health and Social Affairs of Georgia; Ramallah (Palestine): Palestinian Ministry of
education; Palestinian Ministry of health; United Nations Relief and works
Agency (UNRWA) school education dept.; Riga (Latvia): Ethics Committee of
Riga Stradins University. The international coordination and collaboration has
been approved by the ethics committees of the universities of Mu¨nster and Ulm,
Germany [13]. Participation was voluntary and written consent from the parents
was obtained for each child.
Results
Table 1 presents mean BMI and the prevalence of overweight/obesity and the 12-
months prevalence of wheeze for each study centre. An expanded version of the
table, including all health-related outcomes, is included in Table S1 in File S2.
Mean BMI was highest in Almeria (Spain) with 21 kg/m2 and lowest in Mumbai
(India) with 15 kg/m2. The percentage of overweight children (excluding obese
children) ranged from 0.6% in Kintampo (Ghana) to 38.7% in Uruguaiana
(Brazil), and the percentage of obese children from 0 in Kintampo and Mumbai to
22.1% in Almeri`a. Within Europe, there was a gradient with children from the
Mediterranean region being more frequently obese. Wheeze was most frequent in
Brazil (25.6%) and least prevalent in Athens, Greece (5.6%).
Figure 1 shows the relation between BMI and proportion of wheeze in the past
year including children from all centres. A monotonic increase of wheeze with
increase in BMI was seen with no deviation from linearity. There was a slight
indication for a stronger slope for boys than for girls. When we calculated
combined ORs for all centres from meta-analysis, there were no statistically
significant differences between boys and girls. We therefore report results for boys
and girls combined, but also provide additional sex-specific results in Table S7 in
File S2.
The combined OR for wheeze in the past year in relation to overweight and to
obesity was 1.14 (95% confidence interval (CI): 0.98; 1.33) and 1.67 (95%-CI:
1.25; 2.21), respectively (Table 2). The greater part of the centres showed positive
ORs with wheeze for overweight and even more so for obesity (Figure 2). There
was a stronger association in affluent centres than in non-affluent centres
(Tables 2 and 3). This difference between affluent and non-affluent centres was
statistically significant for overweight (p50.024) where no association was seen in
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the non-affluent countries, but not for obesity (p50.267). Within affluent
European centres, there was an indication of a stronger association with obesity
among centres from North-Central Europe (2.84, 95%-CI: 1.67; 4.82) as opposed
to Southern Europe, but much less so for overweight (1.31, 95%-CI: 0.91; 1.89,
Table S3 in File S2).
When looking at wheeze characteristics, we found that wheeze with exercise was
statistically significantly associated with overweight and obesity, especially in
affluent centres, whereas wheeze in the absence of exercise was not. Children
Table 1. Description of the study population: estimates referring to the full sample mean and prevalence are reported (implying appropriate weighting for
stratified subsamples).
Centre N Age BMI Overweight Obese Wheeze
Mean (95%-CI) Mean (95%-CI) N % (95%-CI) N % (95%-CI) N % (95%-CI)
Brazil, Uruguaiana$ 953 9.63 (9.58;9.68) 19.8 (19.6;20.0) 368 38.7 (35.6;41.8) 1-
05
11.1 (9.1;13.1) 2-
45
25.6
(23.7;27.6)
Estonia, Tallinn* 241 10.09 (10.05;10.13) 17.8 (17.5;18.1) 37 15.8 (10.9;20.8) 7 2.8 (0.6;5.0) 55 8.4 (6.7;10.2)
Georgia, Tbilisi* 169 10.41 (10.31;10.50) 18.8 (18.2;19.3) 31 20.1 (13.3;27.0) 12 6.4 (2.3;10.5) 54 9.2 (7.4;11.1)
Germany, Dresden1 694 9.87 (9.84;9.91) 17.4 (17.2;17.6) 100 14.4 (11.8;17.0) 21 3.0 (1.7;4.3) 52 7.9 (6.9;8.8)
Germany, Munich1 886 9.55 (9.51;9.59) 17.9 (17.7;18.1) 168 19.0 (16.4;21.5) 40 4.5 (3.1;5.9) 75 8.3 (7.3;9.2)
Ghana, Kintampo* 241 10.37 (10.28;10.46) 16.1 (16.0;16.3) 1 0.6 (0;1.7) 0 0 81 6.4 (5.1;7.7)
Greece, Athens* 193 9.79 (9.72;9.85) 19.9 (19.4;20.5) 54 27.7 (21.0;34.4) 30 15.4 (10.0;20.9) 37 5.6 (4.2;7.1)
Greece, Thessaloniki* 211 9.74 (9.66;9.82) 20.2 (19.7;20.6) 73 35.8 (28.4;43.3) 40 15.0 (9.6;20.4) 73 8.4 (6.7;10.1)
India, Mumbai* 119 9.77 (9.63;9.92) 15.0 (14.6;15.5) 7 4.9 (0.6;9.2) 0 0 33 6.1 (4.9;7.3)
Italy, Rome$ 1307 10.02 (9.99;10.04) 19.4 (19.2;19.6) 402 30.8 (28.3;33.3) 1-
37
10.5 (8.8;12.1) 1-
03
7.9 (6.5;9.4)
Latvia, Riga1 156 10.54 (10.45;10.63) 18.0 (17.5;18.4) 20 12.8 (7.5;18.1) 3 1.9 (0;4.1) 16 6.9 (5.3;8.6)
Netherlands, Utrecht$ 2638 9.50 (9.45;9.54) 17.8 (17.7;17.9) 413 15.7 (14.3;17.0) 98 3.7 (3.0;4.4) 2-
38
8.7 (7.8;9.6)
New Zealand, Hawkes Bay* 222 10.76 (10.69;10.83) 19.8 (19.3;20.3) 52 22.4 (16.1;28.7) 25 9.5 (5.2;13.7) 11-
1
21.9
(19.7;24.1)
Norway, Tromso* 637 9.94 (9.89;10.00) 17.9 (17.7;18.1) 106 16.0 (13.2;18.9) 25 3.4 (2.1;4.8) 1-
31
14.0
(12.9;15.2)
Palestine, Ramallah* 216 9.73 (9.54;9.91) 17.8 (17.4;18.2) 25 12.2 (7.6;16.8) 10 4.0 (1.4;6.6) 43 8.8 (7.6;9.9)
Spain, Almeria* 208 10.26 (10.15;10.37) 21.0 (20.4;21.7) 65 33.1 (25.2;41.1) 45 22.1 (15.1;29.1) 1-
05
15.5
(13.4;17.7)
Spain, Cartagena* 160 9.53 (9.44;9.63) 18.6 (18.0;19.2) 42 21.7 (14.2;29.2) 17 10.2 (4.6;15.8) 70 11.9
(10.2;13.6)
Spain, Madrid* 408 9.21 (9.15;9.27) 19.3 (18.9;19.6) 114 27.5 (23.1;31.9) 59 14.7 (11.1;18.2) 80 11.6 (9.6;13.7)
Spain, Valencia* 192 9.32 (9.22;9.42) 19.3 (18.8;19.7) 68 35.4 (28.5;42.3) 20 10.4 (6.0;14.8) 28 9.1 (7.6;10.7)
Sweden, Linkoeping* 181 10.72 (10.61;10.82) 19.4 (18.9;19.9) 42 23.6 (16.5;30.7) 14 5.6 (2.0;9.2) 59 7.9 (6.2;9.7)
Sweden, Oestersund* 278 10.70 (10.60;10.80) 18.7 (18.3;19.0) 49 15.5 (10.6;20.4) 17 3.8 (1.4;6.2) 1-
09
10.2 (8.5;12.0)
Turkey, Ankara* 342 9.09 (9.03;9.14) 17.7 (17.4;18.1) 52 17.0 (12.0;22.0) 21 6.9 (3.5;10.3) 1-
60
10.9 (9.8;12.0)
$Full sample;
*Stratified random subsample: 100 children with and 100 children without wheeze were invited.
1Random sample: a random sample without stratification by wheeze was invited.
doi:10.1371/journal.pone.0113996.t001
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reporting more often dry cough at night and those woken with tightness of chest
were more often obese. Effects were most pronounced in North-Central Europe
(Table S3 in File S2). There was no strong evidence for an association with
children woken with shortness of breath. Also, among wheezers, there was no
indication of more severe wheeze in overweight or obese children.
Except for affluence in overweight children, none of the tested potential effect
modifiers gave a statistically significant result (Table 3). For some factors, there
was a slight indication with p-values #0.2 and with a statistically significant
positive associations only in one stratum, namely in physically active children,
children with high birth weight and boys. For rural and urban surroundings, effect
estimates were both positive but higher for rural (p50.1).
None of the three objective measures of BHR, skin prick tests, and total IgE was
conclusively associated with overweight or obesity (Table 2). ORs were close to
one for skin prick test and total IgE, and, while there was an indication of a
Figure 1. Lowess plots i.e. smoothed curves of the average proportion of wheeze in the past year in
relation to BMI (a: boys; b: girls).
doi:10.1371/journal.pone.0113996.g001
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Table 2. Association of wheeze, respiratory and allergy related outcomes and eczema symptoms with overweight and obesity: combined estimates from
meta-analysis, adjusted for sex.
Overweight Obese
OR (95%-CI) N n* OR (95%-CI) N n*
Wheeze past year All centres 1.14 (0.98;1.33) 9658 21 1.67 (1.25;2.21) 7274 18
Affluent 1.27 (1.08;1.50) 7623 14 1.80 (1.28;2.53) 5869 13
Nonaffluent 0.86 (0.65;1.16) 2035 7 1.34 (0.91;1.98) 1405 5
Wheeze with exercise All centres 1.24 (1.01;1.52) 7221 17 1.65 (1.19;2.29) 5995 16
Affluent 1.33 (1.06;1.66) 5580 12 1.58 (1.04;2.38) 4801 12
Nonaffluent 0.88 (0.47;1.63) 1641 5 1.64 (1.00;2.70) 1194 4
Wheeze without exercise All centres 1.10 (0.80;1.52) 5359 13 1.20 (0.81;1.77) 4323 12
Affluent 1.15 (0.76;1.73) 3870 9 1.12 (0.74;1.67) 3329 9
Nonaffluent 0.98 (0.49;1.98) 1489 4 1.48 (0.31;6.99) 994 3
Sleep disturbing wheeze All centres 1.36 (0.99;1.86) 7447 15 2.15 (1.21;3.82) 6338 13
Affluent 1.30 (0.77;2.18) 5981 11 2.27 (1.16;4.44) 5566 11
Nonaffluent 1.44 (0.93;2.21) 1466 4 2.04 (0.46;9.09) 772 2
Dry cough at night All centres 1.13 (1.00;1.29) 9498 21 1.28 (1.07;1.54) 7729 19
Affluent 1.21 (1.05;1.40) 7487 14 1.34 (1.08;1.65) 6341 14
Nonaffluent 0.93 (0.73;1.19) 2011 7 1.32 (0.63;2.79) 1388 5
Woken with shortness of
breath
All centres 1.01 (0.84;1.20) 4221 14 1.35 (0.89;2.04) 2949 11
Affluent 1.06 (0.76;1.48) 2417 8 1.18 (0.62;2.24) 1816 7
Nonaffluent 0.94 (0.59;1.50) 1804 6 1.70 (0.80;3.61) 1133 4
Severe wheeze All centres 1.29 (1.02;1.64) 8525 20 1.69 (1.19;2.38) 6599 19
Affluent 1.37 (1.03;1.80) 6968 14 1.99 (1.31;3.03) 5338 13
Nonaffluent 0.93 (0.43;2.04) 1557 6 1.17 (0.73;1.88) 1261 6
Severe wheeze among
wheezers
All centres 1.14 (0.87;1.50) 1562 18 1.08 (0.77;1.51) 1298 17
Affluent 1.09 (0.81;1.47) 1066 13 1.08 (0.71;1.65) 878 12
Nonaffluent 1.12 (0.57;2.20) 496 5 1.10 (0.59;2.07) 420 5
BHR yes/no All centres 1.05 (0.88;1.26) 5056 19 1.09 (0.81;1.47) 3916 16
Affluent 1.13 (0.93;1.36) 4135 14 1.10 (0.80;1.50) 3515 14
Nonaffluent 0.57 (0.32;1.01) 921 5 1.05 (0.42;2.63) 401 2
Skin prick test All centres 1.04 (0.91;1.18) 7891 21 1.13 (0.91;1.42) 6194 18
Affluent 1.03 (0.90;1.19) 5954 14 1.07 (0.87;1.33) 5004 14
Nonaffluent 1.05 (0.77;1.44) 1937 7 1.49 (0.61;3.67) 1190 4
Total IgE$ All centres 0.95 (0.80;1.12) 4451 15 1.07 (0.82;1.39) 3709 15
Affluent 0.97 (0.81;1.15) 4144 13 1.07 (0.81;1.39) 3571 14
Nonaffluent 0.76 (0.40;1.44) 307 2 Only one centre left
Rhinitis All centres 0.99 (0.88;1.11) 9522 21 1.19 (0.90;1.56) 7746 19
Affluent 0.95 (0.83;1.09) 7506 14 1.07 (0.79;1.45) 6358 14
Nonaffluent 1.11 (0.87;1.41) 2016 7 1.71 (0.94;3.11) 1388 5
Rhinitis with wheeze All centres 1.10 (0.93;1.32) 7161 21 1.73 (1.26;2.38) 5379 18
Affluent 1.12 (0.91;1.38) 5752 14 1.65 (1.10;2.46) 4426 13
Nonaffluent 1.06 (0.76;1.48) 1409 7 1.99 (1.24;3.19) 953 5
Rhinitis without wheeze All centres 0.99 (0.86;1.13) 7878 21 1.13 (0.85;1.51) 6243 18
Affluent 0.96 (0.83;1.12) 6408 14 1.03 (0.75;1.42) 5274 13
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positive association with BHR in Northern-Central Europe, an inverse association
with overweight was observed in non-affluent centres. There was a statistically
significantly lower FEV1/FVC in relation with overweight and obesity in affluent
centres and even more so with obesity in non-affluent centres. FEV1 and FVC
adjusted for age, sex and height, on the contrary, showed an increase of
approximately 80 ml (overweight and obese) for FEV1 and 106 ml (overweight)
and 172 ml (obese) for FVC.
Regarding other allergic disease symptoms (Table 2 and Table S4 in File S2),
rhinitis was not associated with overweight and obesity. For eczema (reported and
examined), there was an association with overweight and obesity in affluent
Table 2. Cont.
Overweight Obese
OR (95%-CI) N n* OR (95%-CI) N n*
Nonaffluent 1.07 (0.80;1.43) 1470 7 1.56 (0.79;3.08) 969 5
Reported eczema past
year
All centres 1.19 (1.02;1.39) 9376 20 1.45 (0.94;2.24) 7471 18
Affluent 1.26 (1.06;1.50) 7494 14 1.62 (0.95;2.79) 6236 13
Nonaffluent 0.98 (0.71;1.35) 1882 6 0.84 (0.49;1.47) 1235 5
Reported eczema
without wheeze
All centres 1.18 (0.99;1.41) 7667 19 1.24 (0.88;1.75) 5900 15
Affluent 1.26 (1.03;1.54) 6290 13 1.34 (0.93;1.92) 5260 12
Nonaffluent 0.94 (0.64;1.37) 1377 6 1.01 (0.35;2.94) 640 3
Eczema by examination All centres 1.36 (0.98;1.87) 6348 14 1.18 (0.70;2.00) 4292 11
Affluent 1.39 (0.98;1.98) 5505 10 1.19 (0.69;2.06) 4154 10
Nonaffluent 1.06 (0.40;2.81) 843 4 Only one centre left
Examined eczema
without wheeze
all centres 1.27 (0.88;1.82) 5366 14 2.07 (1.03;4.17) 2656 7
affluent 1.29 (0.85;1.96) 4802 10 2.25 (1.08;4.68) 2565 6
nonaffluent 1.15 (0.39;3.40) 564 4 Only one centre left
Mean change (%) (95%-CI) N n* Mean change (%) (95%-CI) N n*
FEV1/FVC&# All centres 20.90 (21.33;20.47) 5439 9 22.46 (23.84;21.07) 4746 9
Affluent 20.94 (21.43;20.44) 4970 7 21.59 (22.31;20.86) 4324 7
Nonaffluent 20.79 (22.28;0.70) 469 2 25.39 (29.46;21.31) 422 2
Mean change (ml) N n* Mean change (ml) N n*
FEV1& All centres 80.84 (48.09;113.58) 7926 21 80.26 (52.79;107.74) 6544 19
Affluent 61.34 (42.69;79.99) 6498 14 82.96 (49.28;116.64) 5586 14
Nonaffluent 123.40 (37.86;208.95) 1428 7 53.80 (238.70;146.30) 958 5
Mean change (ml) N n* Mean change (ml) N n*
FVC& All centres 105.57 (84.57;126.56) 5494 9 172.05 (125.68;218.42) 4790 9
Affluent 105.73 (83.97;127.49) 5023 7 157.17 (113.64;200.69) 4367 7
Nonaffluent 103.30 (23.49;183.12) 471 2 265.25 (137.21;393.29) 423 2
*Number of centres.
$Dichotomized at 4.17 kU/l.
&Adjusted for age, sex and height.
#Exclusion of children with difference of FEV1 and FVC.200 ml or difference5212 000 ml.
doi:10.1371/journal.pone.0113996.t002
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countries but not in non-affluent countries. The figures for examined eczema in
obese children should be viewed with caution due to the reduced number of
centres (and children) in the analysis. Looking at respiratory symptoms (Table 4
and Table S5 in File S2), the association of coughed up phlegm with overweight
and obesity was observed mostly when occurring in the absence of a cold or
frequently among children from affluent countries. All associations were
moderately stronger in children who also reported wheeze at the same time (Table
S6 in File S2).
Figure 2. Odds ratios with 95%-confidence intervals (adjusted for sex) for the association of wheeze in
the past year with overweight and obesity.
doi:10.1371/journal.pone.0113996.g002
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Table 3. Association of overweight and obesity with wheeze and effect modification: OR with 95%-confidence intervals adjusted for sex.
OR N n(centres) OR N n(centres) P-value for difference
Affluent countries Nonaffluent countries
Overweight 1.27 (1.08;1.50) 7623 14 0.86 (0.65;1.16) 2035 7 0.024
Obese 1.80 (1.28;2.53) 5869 13 1.34 (0.91;1.98) 1405 5 0.27
Boys Girls
Overweight 1.26 (1.05;1.53) 4801 20 0.98 (0.71;1.34) 4628 19 0.17
Obese 1.94 (1.45;2.60) 3768 18 1.47 (1.08;2.00) 3068 16 0.20
Atopics Nonatopics
Overweight 1.22 (0.95;1.56) 2095 20 1.05 (0.87;1.27) 5328 20 0.35
Obese 1.65 (1.14;2.39) 1403 14 1.70 (1.08;2.66) 3537 16 0.92
Parental allergic disease No parental allergic disease
Overweight 1.10 (0.86;1.41) 4753 18 1.21 (0.98;1.49) 4496 19 0.57
Obese 1.97 (1.49;2.62) 3757 17 1.48 (1.05;2.08) 3190 15 0.20
Parental asthma No parental asthma
Overweight 1.18 (0.84;1.67) 1126 16 1.14 (0.96;1.36) 8078 20 0.86
Obese 1.88 (1.13;3.12) 772 12 1.65 (1.24;2.19) 6066 17 0.66
BHR No BHR
Overweight 1.02 (0.73;1.44) 1126 18 1.12 (0.84;1.49) 3918 19 0.69
Obese 1.37 (0.82;2.28) 825 14 1.94 (1.19;3.16) 2607 14 0.34
Mother smoked in pregnancy No maternal smoking in pregnancy
Overweight 1.21 (0.87;1.68) 1427 10 1.16 (0.98;1.37) 6873 19 0.85
Obese 1.93 (1.24;2.99) 1171 10 1.52 (1.19;1.94) 5063 16 0.35
Fresh fruits intake* No fresh fruits intake
Overweight 1.20 (0.94;1.53) 4233 15 0.88 (0.52;1.49) 414 10 0.29
Obese 1.53 (1.04;2.25) 3227 13 1.35 (0.59;3.07) 252 7 0.78
Med score first tertile1 Med score second and third tertile
Overweight 1.33 (1.03;1.72) 1918 13 1.15 (0.81;1.64) 1841 13 0.51
Obese 1.50 (1.05;2.14) 1449 11 1.41 (0.95;2.10) 1380 11 0.82
Physical activity+ Physical activity2
Overweight 1.32 (1.01;1.74) 2656 13 0.93 (0.63;1.38) 817 11 0.15
Obese 1.69 (1.04;2.76) 2075 12 1.07 (0.61;1.88) 676 11 0.23
Urban$ Rural$
Overweight 1.08 (0.81;1.45) 3401 18 1.22 (0.91;1.62) 2095 15 0.58
Obese 1.24 (0.92;1.66) 2262 13 2.05 (1.22;3.45) 1470 13 0.10
Low birth weight& Normal birth weight&
Overweight 1.65 (0.89;3.06) 417 11 1.09 (0.83;1.42) 2746 17 0.23
Obese 2.54 (0.86;7.50) 159 4 1.35 (0.82;2.23) 1996 14 0.30
High birthweight& Normal birth weight&
Overweight 1.40 (1.08;1.82) 1816 15 1.09 (0.83;1.42) 2746 17 0.18
Obese 2.10 (1.49;2.98) 1508 15 1.35 (0.82;2.23) 1996 14 0.15
+Physical activity: 2 times a week or more often; *Fresh fruits are consumed 1 time per week or more often; 1Med.Score: higher scores for more frequent
consumption of vegetables (raw green and cooked), fruit, fruit juice and fish, and lower scores for more frequent consumption of meat, burger and fizzy
drinks (for details see File S1 and S2); &Low birthweight: less than 2500 g, normal: 2500–3499 g, high: more than 3500 g; $urban: suburban, with few parks
or gardens or urban with no parks or gardens, rural: rural, open spaces or fields nearby or suburban, with many parks or gardens.
doi:10.1371/journal.pone.0113996.t003
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Discussion
This large international multi-centre study, including both affluent and non-
affluent countries, provides evidence that excess weight is associated with
asthmatic symptoms as well as eczema, and rhinitis in combination with
asthmatic symptoms. No association was observed for objective measures of
allergic disease such as BHR, skin prick test, or total IgE. BMI was inversely
associated with FEV1/FVC, an indicator of airway obstruction.
In our study, we found a linear association between BMI and wheeze indicating
a dose-response relationship. However, other authors observed a U-shaped BMI-
asthma relationship, when applying BMI categories [19]. We found a stronger
association with wheeze for overweight in affluent countries and within Europe an
indication for a stronger association with obesity in Northern-Central than in
Southern European centres. A dose response pattern was also found for coughed
Table 4. Association of cough and phlegm with overweight and obesity: combined estimates from meta-analysis adjusted for sex.
Overweight Obese
OR (95%-CI) N n* OR (95%-CI) N n*
Coughed up phlegm with colds
All centres 1.11 (0.94;1.30) 7646 17 1.26 (0.96;1.66) 6251 16
Affluent 1.19 (1.00;1.43) 5824 11 1.32 (0.95;1.83) 4908 11
Nonaffluent 0.96 (0.77;1.21) 1822 6 0.86 (0.37;1.99) 1343 5
Coughed up phlegm with colds without wheeze
All centres 1.03 (0.84;1.26) 6255 17 1.25 (0.98;1.59) 4949 15
Affluent 1.06 (0.82;1.38) 4946 11 1.27 (0.95;1.70) 4158 11
Nonaffluent 0.94 (0.72;1.22) 1309 6 1.11 (0.71;1.74) 791 4
Coughed up phlegm without colds
All centres 1.17 (0.98;1.40) 7541 17 1.64 (1.15;2.34) 5840 14
Affluent 1.30 (0.99;1.71) 5755 11 1.73 (1.10;2.71) 4859 11
Nonaffluent 1.12 (0.80;1.58) 1786 6 1.13 (0.38;3.30) 981 3
Coughed up phlegm without colds without wheeze
All centres 1.07 (0.83;1.37) 5375 13 1.86 (1.32;2.63) 4418 10
Affluent 1.10 (0.78;1.56) 4176 8 1.88 (1.27;2.80) 3846 8
Nonaffluent 1.13 (0.63;2.05) 1199 5 1.78 (0.76;4.17) 572 2
Congested in chest/coughed up phlegm frequently1
All centres 1.44 (1.15;1.79) 6935 15 2.28 (1.70;3.07) 5482 13
Affluent 1.70 (1.29;2.25) 5363 10 2.53 (1.62;3.93) 4546 10
Nonaffluent 0.91 (0.49;1.68) 1572 5 2.01 (1.26;3.22) 936 3
Congested in chest/coughed up phlegm frequently1 without wheeze
All centres 1.52 (1.00;2.30) 4947 11 2.71 (1.76;4.17) 3824 9
Affluent 1.87 (1.24;2.82) 3915 7 2.93 (1.55;5.52) 3270 7
Nonaffluent 0.85 (0.46;1.60) 1032 4 2.65 (1.28;5.50) 554 2
*Number of centres.
1On 4 or more days a week for as much as 3 months a year.
doi:10.1371/journal.pone.0113996.t004
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up phlegm. Stronger associations due to more power could be attributed to higher
prevalence of weight excess in western countries [20].
A lower FEV1/FVC was observed in overweight and obese children from both,
affluent and non-affluent countries. However, it should be acknowledged that
data on FVC was only available in a subset. Literature examining the association
between obesity and lung function is conflicting. Height has been identified as the
important independent predictor of spirometric variables and the therefore
resulting collinearity of FEV1 and FVC with BMI limits the interpretation of these
parameters on their own [21]. Our observation that the effects of obesity on
FEV1/FVC are related to an increase in FVC, rather than a decrease in FEV1 has
therefore to be interpreted with caution. In a certain proportion of children, BMI
may reflect increased muscular mass and be correlated with higher lung volumes
and therefore influence the observed relationship with FVC and FEV1,
respectively [22], while this effect is cancelled out in the ratio between them.
Nevertheless, the reduction of FEV1/FVC but no increase of BHR could suggest
that overweight and obesity are not related to the common asthma phenotype
associated with BHR. Indeed, there is cumulating evidence that asthma is a
heterogeneous disease with different phenotypes and potential different
pathological mechanisms [23, 24]. Obesity and asthma are believed to share
common genetic determinates [25] and it has been suggested that obesity results
in a distinct asthma phenotype [26], characterized by more severe disease, with
increased exacerbation, poorer asthma control and steroid responsiveness. In our
study, wheeze with exercise, dry cough at night, woken at night with tightness of
chest and coughed up phlegm without a cold were found more frequently among
overweight and obese children. This could reflect differential patterns of asthma
phenotypes between normal weight as opposed to overweight/obese children. The
stronger association of wheeze with overweight/obesity in affluent countries, in
particular countries from Northern-Central Europe, may possibly reflect an
increased prevalence of an obesity-related asthma phenotype.
In our study, the association between excess weight and wheeze was not related
to atopic status. This contradicts some previous reports on stronger associations
for non-atopic asthma, but is in line with the observations that have not found an
effect modification by atopy [2]. Consistent with the literature, we found no
evidence that overweight and obesity is associated with allergic sensitization [27].
Our observation of mixed results for BHR in affluent countries and non-affluent
countries fits with the heterogeneous results from former publications [10, 19, 28].
For reported eczema we observed increased prevalence among obese children with
asthma symptoms in agreement with cross-sectional and longitudinal studies
[12, 29], and the data for clinical examination of eczema seem to corroborate
these results.
We did not find strong evidence for an association between overweight and
obesity and allergic disease, since only rhinitis in combination with wheeze and
none of the objective measures for allergy was associated with overweight and
obesity. This is in line with other studies including objective markers [29]
suggesting a non-eosinophil inflammatory mechanism is associated with asthma.
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Obesity is thought to be linked with asthma by obesity-related systemic
inflammation, which could promote exaggerated responses to environmental
triggers [1]. Obesity is associated with low-grade inflammation and adipokines,
which have been found to be related to asthma symptoms [30].
In our study, the association of overweight and obesity with asthma symptoms
did not differ between girls and boys. In previous cross-sectional and longitudinal
studies, gender-differences have been reported in some [8, 11, 29] but not in other
studies [2, 9, 12, 27, 29].
We observed stronger associations between overweight and asthma in affluent
and in particular Northern-Central European countries than in non-affluent
countries. Differences of asthma prevalence according to affluence status are well
established [31]. Lifestyle and standards of living are suggested to contribute to
these disparities, and may also reflect partly different structures of residual
confounding as indicated by former ISAAC II publications on breastfeeding [32],
diet [33], infections [34], and dampness [35]. The existence of different asthma
phenotypes [24] may also contribute to the observed pattern. Epidemiological
studies in adults and also children revealed ethnic differences in fat deposits [36]
which can also apply in different relationships of the fat mass and fat free mass in
children. The differences could contribute to geographic changes in the
associations of BMI with asthma and allergic diseases.
Several possible limitations of the study need to be considered. Parental
reporting on disease symptoms, in particular for asthma, could have been
influenced by obesity, since in adults over-diagnosis of asthma has been matter of
concern [30]. In our study, however, the positive associations between obesity and
wheeze were also present when considering lung function. Residual confounding
could have affected the associations. However, by further adjustment for dietary
factors such as fruit and vegetable intake, Mediterranean diet score or physical
activity the associations between obesity and asthma symptoms did not change.
Other comorbid conditions related to obesity could have influenced the
occurrence of asthma [37]. As we investigated a number of outcomes, we cannot
exclude the possibility of a sporadic chance finding among the findings which are,
however, quite consistent in their overall pattern. In large worldwide studies, a
difficulty is that information may not be comparable across geographical regions
and therefore covariates may not reflect exactly the same underlying confounders.
This may have limited our ability to find and adjust for relevant confounders, so
that we cannot exclude fully the possibility of residual confounding. On the other
hand the presence of quite consistent associations across these geographical
regions is reassuring, decreasing the probability that the overall result is due to
residual confounding, only.
Further strengths of the study are the use of the standardized ISAAC
questionnaires and methodology in all centres and the inclusion of non-affluent
countries. Another strength is that BMI has been measured according to a
standard protocol extending the work from ISAAC Phase Three which was largely
based on reported values [12]. Furthermore, we were able to investigate
standardized objective measurements for lung function and allergic disease in a
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large international study. However, due to the cross-sectional study design reverse
causation cannot be completely excluded.
Conclusion
Our observations in a large international child population strengthen previous
reports that overweight and obesity are associated with wheeze and asthma in
childhood as well as objective evidence of airways obstruction. No other objective
markers of respiratory and allergic disorders were involved. The significance of
these observations needs to be confirmed in prospective studies and experimental
trials.
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